S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.02 (+0.38%)
AAPL   161.38 (-0.63%)
MSFT   297.50 (+0.50%)
FB   307.28 (+1.36%)
GOOGL   2,616.31 (+0.36%)
AMZN   2,886.55 (+1.18%)
TSLA   925.69 (-1.93%)
NVDA   233.15 (-0.25%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.73 (-1.75%)
CGC   7.40 (+1.51%)
MU   82.87 (+1.15%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.02 (+0.38%)
AAPL   161.38 (-0.63%)
MSFT   297.50 (+0.50%)
FB   307.28 (+1.36%)
GOOGL   2,616.31 (+0.36%)
AMZN   2,886.55 (+1.18%)
TSLA   925.69 (-1.93%)
NVDA   233.15 (-0.25%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.73 (-1.75%)
CGC   7.40 (+1.51%)
MU   82.87 (+1.15%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.02 (+0.38%)
AAPL   161.38 (-0.63%)
MSFT   297.50 (+0.50%)
FB   307.28 (+1.36%)
GOOGL   2,616.31 (+0.36%)
AMZN   2,886.55 (+1.18%)
TSLA   925.69 (-1.93%)
NVDA   233.15 (-0.25%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.73 (-1.75%)
CGC   7.40 (+1.51%)
MU   82.87 (+1.15%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.02 (+0.38%)
AAPL   161.38 (-0.63%)
MSFT   297.50 (+0.50%)
FB   307.28 (+1.36%)
GOOGL   2,616.31 (+0.36%)
AMZN   2,886.55 (+1.18%)
TSLA   925.69 (-1.93%)
NVDA   233.15 (-0.25%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.73 (-1.75%)
CGC   7.40 (+1.51%)
MU   82.87 (+1.15%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)

3M Stock Competitors

$172.80
+0.15 (+0.09%)
(As of 01/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$168.83
$173.21
50-Day Range
$170.04
$183.37
52-Week Range
$168.23
$208.95
Volume
4.71 million shs
Average Volume
2.58 million shs
Market Capitalization
$99.99 billion
P/E Ratio
16.96
Dividend Yield
3.43%
Beta
0.96

3M (NYSE:MMM) Vs. SYK, BDX, BSX, BAX, DXCM, RMD, PODD, TFX, ABMD, and PEN

Should you be buying 3M stock or one of its competitors? The main competitors of 3M include Stryker (SYK), Becton, Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Insulet (PODD), Teleflex (TFX), Abiomed (ABMD), and Penumbra (PEN). These companies are all part of the "industrial conglomerates" industry.These companies are all part of the "surgical & medical instruments" industry.

3M vs.

3M (NYSE:MMM) and Becton, Dickinson and (NYSE:BDX) are both large-cap multi-sector conglomerates companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, community ranking, earnings and risk.

3M pays an annual dividend of $5.92 per share and has a dividend yield of 3.4%. Becton, Dickinson and pays an annual dividend of $3.48 per share and has a dividend yield of 1.3%. 3M pays out 58.1% of its earnings in the form of a dividend. Becton, Dickinson and pays out 50.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

3M has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. Comparatively, Becton, Dickinson and has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.

In the previous week, Becton, Dickinson and had 6 more articles in the media than 3M. MarketBeat recorded 10 mentions for Becton, Dickinson and and 4 mentions for 3M. Becton, Dickinson and's average media sentiment score of 0.42 beat 3M's score of 0.07 indicating that Becton, Dickinson and is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
3M
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Becton, Dickinson and
3 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

3M received 320 more outperform votes than Becton, Dickinson and when rated by MarketBeat users. Likewise, 64.18% of users gave 3M an outperform vote while only 63.03% of users gave Becton, Dickinson and an outperform vote.

CompanyUnderperformOutperform
3MOutperform Votes
869
64.18%
Underperform Votes
485
35.82%
Becton, Dickinson andOutperform Votes
549
63.03%
Underperform Votes
322
36.97%

66.2% of 3M shares are held by institutional investors. Comparatively, 84.0% of Becton, Dickinson and shares are held by institutional investors. 0.3% of 3M shares are held by insiders. Comparatively, 0.5% of Becton, Dickinson and shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

3M has a net margin of 16.90% compared to Becton, Dickinson and's net margin of 10.22%. 3M's return on equity of 42.80% beat Becton, Dickinson and's return on equity.

Company Net Margins Return on Equity Return on Assets
3M 16.90% 42.80% 12.50%
Becton, Dickinson and 10.22% 15.97% 7.13%

3M presently has a consensus target price of $188.54, suggesting a potential upside of 9.11%. Becton, Dickinson and has a consensus target price of $272.43, suggesting a potential upside of 4.80%. Given 3M's higher probable upside, research analysts clearly believe 3M is more favorable than Becton, Dickinson and.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
3M
4 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.86
Becton, Dickinson and
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29

3M has higher revenue and earnings than Becton, Dickinson and. 3M is trading at a lower price-to-earnings ratio than Becton, Dickinson and, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
3M$32.18 billion3.11$5.38 billion$10.1916.96
Becton, Dickinson and$20.25 billion3.66$2.09 billion$6.8537.95

Summary

3M beats Becton, Dickinson and on 11 of the 19 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MMM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

3M (NYSE:MMM) vs. Its Competitors

Type3MSurgical & medical instruments IndustryMulti-Sector SectorNYSE Exchange
Market Cap$99.99B$3.88B$19.89B$14.90B
Dividend Yield3.43%1.35%2.77%3.58%
P/E Ratio16.9623.9515.3821.26
Price / Sales3.11152.2347.9822.89
Price / Cash14.6964.6820.2783.04
Price / Book7.717.632.1411.49
Net Income$5.38B$84.13M$985.13M$427.16M
7 Day Performance-3.32%-7.96%-5.06%-5.15%
1 Month Performance-1.24%-11.88%-4.16%-4.89%
1 Year Performance2.22%-14.15%12.28%9.35%

3M Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SYK
Stryker
3.1498 of 5 stars
$251.92
+1.1%
$294.84
+17.0%
+6.1%$95.00B$14.35B50.6943,000Upcoming Earnings
BDX
Becton, Dickinson and
2.665 of 5 stars
$259.96
+1.8%
$272.43
+4.8%
+2.3%$74.10B$20.25B37.9570,000News Coverage
BSX
Boston Scientific
2.3414 of 5 stars
$42.66
+0.7%
$49.90
+17.0%
+16.0%$60.79B$9.91B58.4438,000
BAX
Baxter International
2.9927 of 5 stars
$85.96
+0.4%
$95.30
+10.9%
+8.5%$43.04B$11.67B35.9750,000
DXCM
DexCom
2.7679 of 5 stars
$426.83
+1.1%
$587.64
+37.7%
+14.0%$41.37B$1.93B81.616,400
RMD
ResMed
2.2165 of 5 stars
$238.52
+1.4%
$254.00
+6.5%
+9.1%$34.76B$3.20B69.957,970Upcoming Earnings
Analyst Upgrade
PODD
Insulet
2.1637 of 5 stars
$223.00
+0.5%
$313.88
+40.8%
-22.8%$15.38B$904.40M-495.561,900Gap Down
TFX
Teleflex
2.9465 of 5 stars
$317.29
+1.9%
$411.90
+29.8%
-16.4%$14.86B$2.54B34.6814,000Analyst Report
Gap Down
ABMD
Abiomed
2.2064 of 5 stars
$311.94
+2.4%
$375.50
+20.4%
-12.5%$14.19B$847.52M96.281,725Analyst Revision
Gap Down
PEN
Penumbra
2.575 of 5 stars
$228.46
+4.4%
$329.75
+44.3%
-10.5%$8.54B$560.41M251.053,300Gap Down
TNDM
Tandem Diabetes Care
2.4173 of 5 stars
$125.23
+1.5%
$146.38
+16.9%
+25.1%$7.96B$498.83M431.831,500Positive News
NVCR
NovoCure
2.3048 of 5 stars
$68.94
+2.6%
$154.83
+124.6%
-60.3%$7.16B$494.37M-255.331,023Analyst Revision
Gap Down
GMED
Globus Medical
2.7673 of 5 stars
$68.66
+1.1%
$88.45
+28.8%
+4.0%$6.93B$789.04M37.932,200
INSP
Inspire Medical Systems
2.2048 of 5 stars
$210.52
+1.8%
$313.75
+49.0%
-6.4%$5.76B$115.38M-120.99341Gap Down
IART
Integra LifeSciences
1.9987 of 5 stars
$67.24
+1.0%
$76.50
+13.8%
-3.9%$5.70B$1.37B26.473,700
SWAV
ShockWave Medical
2.2948 of 5 stars
$143.17
+5.9%
$236.40
+65.1%
+3.6%$5.05B$67.79M-130.152,019Insider Selling
Gap Down
ICUI
ICU Medical
2.2048 of 5 stars
$213.21
+1.3%
$283.00
+32.7%
-4.6%$4.53B$1.27B42.307,900
IRTC
iRhythm Technologies
1.9364 of 5 stars
$125.51
+2.6%
$156.67
+24.8%
-49.1%$3.69B$265.17M-46.831,157Gap Down
NARI
Inari Medical
2.9083 of 5 stars
$73.11
+4.9%
$128.25
+75.4%
-35.1%$3.67B$139.67M270.79456Gap Down
MMSI
Merit Medical Systems
2.1964 of 5 stars
$57.49
+3.1%
$77.60
+35.0%
-3.6%$3.25B$963.88M75.655,989News Coverage
Positive News
NUVA
NuVasive
2.2869 of 5 stars
$57.50
+0.5%
$65.67
+14.2%
+1.5%$2.97B$1.05B-112.752,700
ATRC
AtriCure
2.2971 of 5 stars
$63.45
+3.2%
$86.29
+36.0%
+4.0%$2.91B$206.53M66.79750
HAE
Haemonetics
2.2515 of 5 stars
$49.96
+1.8%
$73.00
+46.1%
-58.0%$2.55B$870.46M83.272,708
NVRO
Nevro
2.2698 of 5 stars
$71.50
+20.1%
$115.30
+61.3%
-51.2%$2.50B$362.05M-22.92843Gap Down
High Trading Volume
GKOS
Glaukos
1.8775 of 5 stars
$51.16
+0.4%
$59.00
+15.3%
-41.1%$2.40B$224.96M-60.19653Gap Down
AXNX
Axonics
2.2848 of 5 stars
$50.67
+2.6%
$73.17
+44.4%
-12.8%$2.35B$111.54M-27.69416Gap Down
SKIN
Beauty Health
2.1472 of 5 stars
$13.63
+0.1%
$29.71
+118.0%
N/A$2.04BN/A0.002Gap Down
ATRI
Atrion
2.2998 of 5 stars
$650.50
+5.1%
N/A-16.2%$1.17B$147.59M36.75636Gap Up
High Trading Volume
SILK
Silk Road Medical
1.9615 of 5 stars
$32.99
+3.7%
$56.00
+69.7%
-47.3%$1.15B$75.23M-21.85281Gap Down
FNA
Paragon 28
1.825 of 5 stars
$14.76
+5.8%
$30.00
+103.3%
N/A$1.13BN/A0.002,021Gap Down
BVS
Bioventus
1.6264 of 5 stars
$14.22
+0.9%
$21.33
+50.0%
N/A$1.07B$321.16M-284.40700Positive News
ATEC
Alphatec
2.4148 of 5 stars
$10.59
+3.3%
$18.83
+77.8%
-30.9%$1.05B$144.86M-7.41296Gap Down
KIDS
OrthoPediatrics
2.7048 of 5 stars
$50.30
+5.5%
$75.40
+49.9%
+8.4%$989.80M$71.08M-32.04116
TMCI
Treace Medical Concepts
1.9917 of 5 stars
$18.42
+0.5%
$33.50
+81.9%
N/A$979.45MN/A0.00133Gap Down
LMAT
LeMaitre Vascular
3.2031 of 5 stars
$44.18
+0.8%
$64.25
+45.4%
-3.5%$964.80M$129.37M33.47395
LUNG
Pulmonx
2.1715 of 5 stars
$25.02
+4.8%
$53.80
+115.0%
-63.8%$921.71M$32.73M-20.34220Gap Down
CERS
Cerus
1.6114 of 5 stars
$5.33
+2.4%
N/A-28.4%$918.18M$91.92M-15.23266Gap Down
High Trading Volume
XENT
Intersect ENT
1.5914 of 5 stars
$27.20
+0.3%
$28.28
+4.0%
+2.0%$910.17M$80.55M-10.15406News Coverage
ANGO
AngioDynamics
2.3181 of 5 stars
$22.82
+3.1%
$32.00
+40.2%
+21.5%$883.52M$291.01M-23.05800
LGV
Longview Acquisition Corp. II
0.3333 of 5 stars
$9.74
+0.1%
N/AN/A$840.08MN/A0.003News Coverage
High Trading Volume
INO
Inovio Pharmaceuticals
1.9083 of 5 stars
$3.92
+0.0%
$12.60
+221.4%
-56.4%$824.71M$7.41M-3.60262Analyst Upgrade
Analyst Revision
Gap Down
PRCT
Procept BioRobotics
2.0133 of 5 stars
$17.62
+1.8%
$47.00
+166.7%
N/A$766.42MN/A0.002,021Gap Down
CSII
Cardiovascular Systems
2.0219 of 5 stars
$18.79
+3.8%
$43.40
+131.0%
-61.3%$761.95M$258.97M-36.84779
CRY
CryoLife
2.6248 of 5 stars
N/A$32.00
+∞
-29.2%$703.22M$253.23M596.201,200
SGHT
Sight Sciences
2.325 of 5 stars
$14.85
+2.3%
$40.50
+172.7%
N/A$702.51MN/A0.002,021Gap Down
SIBN
SI-BONE
2.2314 of 5 stars
$20.70
+2.9%
$34.80
+68.1%
-35.6%$693.24M$73.39M-13.35295Analyst Upgrade
OFIX
Orthofix Medical
1.4931 of 5 stars
$32.00
+1.2%
N/A-28.0%$631.84M$406.56M-41.561,036
OSUR
OraSure Technologies
2.0848 of 5 stars
$8.74
+0.8%
$13.83
+58.3%
-36.5%$629.61M$171.72M-58.27570News Coverage
SRDX
Surmodics
2.2314 of 5 stars
$44.39
+1.0%
$70.00
+57.7%
-4.2%$620.35M$105.14M147.97370
ATRS
Antares Pharma
2.4514 of 5 stars
$3.41
+4.1%
$6.00
+76.0%
-28.3%$579.84M$149.60M8.97185Analyst Revision
News Coverage
This page was last updated on 1/24/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.